AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Hemab Therapeutics Holdings, Inc. Common Stock
$41.45
+$7.45 (+21.91%)
Previous Close
$40.42
Day Range
$39.38$42.85
Year Range
$23.00$55.42
Market Cap
1.94B
AVG Volume
438.66K
Trailing/Forward PE
-31.64/-
PEG ratio
0.33
Dividend Yield
-
Next Earnings Date
2026-11-10
Primary Exchange
NASDAQ
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: COAG
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Nov 2026.
Video analysis: COAG
All videosNo video analysis for this stock yet. Request one from our team.
